Related by context. Frequent words. (Click for all words.) 65 Initiates Phase II 64 Files Shelf Registration Statement 64 NASDAQ OSIR 63 Inc Therapeutic Competitors 62 Nasdaq ENMD 61 Inc. Nasdaq VVUS 61 SmarTrend Biotechnology 61 Therapeutic Competitors 60 Inc. Nasdaq MEDX 60 NASDAQ LGND 60 Inc. Nasdaq IMGN 59 Q2 Loss Narrows 59 refractory chronic lymphocytic 59 Nasdaq ASTM 59 Nasdaq VRTX 59 Q2 Loss Widens 59 Trofex 59 Nasdaq ENZN 59 NASDAQ DYAX 58 Inc. Nasdaq TRMS 58 Welcomes Analyst Initiation 58 Nasdaq VICL 58 TSX PLB leading 58 www.vivus.com 58 Inc. NASDAQ MRNA 58 Prestara 58 Q3 Loss Narrows 58 Inc. Nasdaq SUPG 58 PRNewswire FirstCall Cell Therapeutics 58 TSX TLN 58 deforolimus 57 Shareholders Approve Acquisition 57 CardioVascular BioTherapeutics Inc. 57 www.combinatorx.com 57 risks anduncertainties 57 Entereg R 57 NASDAQ CYPB 57 BioGlue R 57 AMRI NASDAQ 57 Pharmion Corporation 57 Nasdaq REGN 57 Files Annual Report 57 inflammatory autoimmune diseases 56 MorphoSys AG FSE MOR 56 Q4 Loss Narrows 56 MedCom USA Inc. 56 Announces Stockholder Approval 56 ALN TTR 56 NASDAQ STEM 56 Deloitte commends 56 Stockholders Approve Merger 56 theSecurities 56 Sunesis Pharmaceuticals Inc. 56 Metabasis Therapeutics Inc. 56 VALSTAR 56 timelines communicated 56 Panzem R 56 Fibrillex TM 56 EPIX Pharmaceuticals 56 Inc. NASDAQ HGSI 56 autoimmune indications 56 Bayhill Therapeutics 55 Inc. Nasdaq EXEL 55 Updates Guidance 55 TranSwitch filings 55 Nasdaq BDSI 55 Visudyne R 55 forodesine 55 Idera Pharmaceuticals 55 Eligard R 55 Universal Shelf Registration 55 ACLARA 55 Allovectin 7 R 55 THALOMID 55 Phase IIb trials 55 NASDAQ OPXA 55 ThermoDox R 55 submitted Biologics License 55 ImmunoCellular Therapeutics 55 Inc. NASDAQ CLDA 55 PLK1 SNALP 55 forodesine HCl 55 Alzhemed TM 55 LYON France BUSINESS WIRE 55 Guided Therapeutics 55 Oscient Pharmaceuticals Corporation 55 OTCBB NEOP diversified 55 TELINTRA 55 SILENOR TM 55 Inc. NASDAQ ANPI 55 OncoGenex Pharmaceuticals Inc. 55 Vicor Technologies Inc. 54 CTI Nasdaq 54 MTA CTIC 54 Ligand Pharmaceuticals Incorporated 54 Releases Third Quarter 54 Joins OTCQX 54 Crucell NV Euronext 54 NASDAQ SCLN 54 HepaLife Technologies Inc. 54 DayTradersDigest.com